Changes of PCS and MCS before and after Treatment for Patients Receiving ECT and Fluoxetine
| . | ECT . | Fluoxetine . | Pa . | ||
|---|---|---|---|---|---|
| Variables . | n . | . | n . | . | . |
| SF-36 PCS change, mean (SD) | 95 | 6.1 (9.4) | 106 | 1.3 (9.3) | <.001 |
| SF-36 MCS change, mean (SD) | 95 | 12.0 (11.2) | 106 | 6.4 (11.6) | .013 |
| . | ECT . | Fluoxetine . | Pa . | ||
|---|---|---|---|---|---|
| Variables . | n . | . | n . | . | . |
| SF-36 PCS change, mean (SD) | 95 | 6.1 (9.4) | 106 | 1.3 (9.3) | <.001 |
| SF-36 MCS change, mean (SD) | 95 | 12.0 (11.2) | 106 | 6.4 (11.6) | .013 |
aP values were determined by ANCOVA, with sex, age, age at onset, and baseline value as a covariate.
Bold, statistically significant.
Changes of PCS and MCS before and after Treatment for Patients Receiving ECT and Fluoxetine
| . | ECT . | Fluoxetine . | Pa . | ||
|---|---|---|---|---|---|
| Variables . | n . | . | n . | . | . |
| SF-36 PCS change, mean (SD) | 95 | 6.1 (9.4) | 106 | 1.3 (9.3) | <.001 |
| SF-36 MCS change, mean (SD) | 95 | 12.0 (11.2) | 106 | 6.4 (11.6) | .013 |
| . | ECT . | Fluoxetine . | Pa . | ||
|---|---|---|---|---|---|
| Variables . | n . | . | n . | . | . |
| SF-36 PCS change, mean (SD) | 95 | 6.1 (9.4) | 106 | 1.3 (9.3) | <.001 |
| SF-36 MCS change, mean (SD) | 95 | 12.0 (11.2) | 106 | 6.4 (11.6) | .013 |
aP values were determined by ANCOVA, with sex, age, age at onset, and baseline value as a covariate.
Bold, statistically significant.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
